The life sciences practice at Mattos Filho brings extensive experience in regulatory, contractual, and litigation matters across the life sciences and healthcare sectors. The team’s recent highlights include advising on product recalls, regulatory implications of corporate acquisitions, and contract structuring for business growth. The firm also frequently acts in negotiations between pharmaceutical companies and public entities. Ana Cândida Sammarco leads on engagements involving ANVISA and the National Supplementary Health Agency (ANS), providing strategic advice to a broad client base comprising both international and domestic players. Gustavo Swenson Caetano is highly regarded for his work on transactional, regulatory, and IP matters within the life sciences, food, agribusiness, and biotechnology industries.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Mattos Filho stands out for its unique combination of deep technical knowledge and practical approach to solving legal problems.'
- 'The team demonstrates exceptional skill in distinguishing theoretical risks from practical ones, offering effective, results-oriented solutions. Its agility and responsiveness are remarkable, as is its ability to maintain excellent client relationships. This combination of technical expertise, pragmatism, and efficiency positions Mattos Filho as a leader in the Brazilian legal sector, offering exceptional value to its clients.'
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Other key lawyers
Ana Cândida Sammarco; Gustavo Swenson Caetano